Kiran Kundu

Beersheba, D 84105, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.

BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.

Journal: Science translational medicine

Published: September 11, 2024

CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis.

CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis.

Journal: Cancer discovery

Published: January 18, 2024

SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer.

SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer.

Journal: Translational lung cancer research

Published: May 29, 2021

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology.

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 04, 2021

Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity.

Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity.

Journal: Scientific reports

Published: August 05, 2020

Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology.

Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology.

Journal: bioRxiv : the preprint server for biology

Published: June 25, 2020

Synthetic promoters to induce immune-effectors into the tumor microenvironment.

Synthetic promoters to induce immune-effectors into the tumor microenvironment.

Journal: Communications biology

Published: January 30, 2020

N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion.

N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion.

Journal: Frontiers in cellular and infection microbiology

Published: August 27, 2019

Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA.

Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA.

Journal: Cancer immunology research

Published: January 11, 2019

Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy.

Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy.

Journal: Frontiers in oncology

Published: October 18, 2018

NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death.

NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death.

Journal: Frontiers in immunology

Published: February 06, 2018

Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints.

Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints.

Journal: Cancer immunology, immunotherapy : CII

Published: July 30, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026